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EDITORIAL COMMENT
Linear Ablation
for Atrial Fibrillation
Have We Come Full Circle?*
David J. Wilber, MD, FACC
Maywood, Illinois
The evolution of effective and broadly applicable strategies
for percutaneous ablation of atrial fibrillation (AF) has
followed a complex course over the past decade. In 1994,
Swartz et al. (1) reported successful percutaneous ablation of
AF with multiple long linear lesions. Conceived as a
replication of the surgical MAZE, the procedure deployed
specifically tailored long sheaths to facilitate fluoroscopically
guided sequential radiofrequency application along a prede-
termined set of ablation lines in both atria. Subsequent
long-term follow-up in 40 patients with chronic AF dem-
onstrated the remarkable efficacy of this procedure (90% in
sinus rhythm), but with prolonged procedure times (10 to
15 h), and a 22% incidence of major complications (includ-
ing stroke, significant pericardial effusion/tamponade, and
pulmonary vein [PV] occlusion) (2).
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Other groups subsequently tested a variety of linear
strategies employing the sequential application technique in
attempts to simplify the procedure and reduce risks, pre-
dominantly in patients with paroxysmal AF (3–8). Several
lessons emerged from that experience. Right atrial lesions
alone or in combination with left linear lesions appeared to
contribute little to overall procedural efficacy and were
largely abandoned. During follow-up, elimination of AF
without antiarrhythmic drugs occurred in 40% to 50% of
patients with left linear lesions; an additional 20% had
complete suppression of AF after adjunctive antiarrhythmic
drug therapy. These results fell short of the 80% to 90%
success rates reported for surgically based simplified MAZE
procedures (9,10), as well as the original Swartz procedure.
Continuous transmural lesions were technically difficult to
produce, and gaps in the ablation line resulted not only in
recurrent AF, but also promoted a new form a proarrhyth-
mia, left atrial (LA) macroreentry, often requiring addi-
tional intervention. Subsequent experimental data con-
firmed that gaps from 2 to 5 mm were capable of permitting
conduction and could facilitate LA macroreentry (11,12).
Use of irrigated catheters did not completely eliminate the
problem of incomplete lines (7). Finally, the risk of major
complications associated with these procedures remained
substantial (12).
With the recognition of venous triggers for AF initiation
and maintenance by Haı¨ssaguerre et al. (13), enthusiasm for
long linear lesion strategies waned. Initial approaches tar-
geted spontaneous focal triggers within one or more “ar-
rhythmogenic” PVs (13,14). However, the unreliable prov-
ocation of focal firing in the laboratory, frequent recurrences
necessitating repeated interventions, and a modest risk of
PV stenosis led to procedural modifications whereby focal
segmental ablation was performed at the LA-PV junction,
with the aim of electrical disconnection of the vein from the
LA (15). The use of circular recording catheters that could
monitor electrograms around the circumference of the vein
facilitated this approach (16). Elimination of high frequency
potentials indicative of local activation from within the vein
during atrial pacing (entrance block) and the inability of
paced or spontaneous depolarizations within the vein to
activate the LA (exit block) became easily recognized and
well-defined acute end points. Extension of the segmental
ostial isolation procedure to all four PVs resulted in suc-
cessful elimination of paroxysmal AF in 70% to 80% of such
patients during short-term follow-up, with a low risk of
symptomatic PV stenosis and other major complications
(17–19). The reported success of this procedure for persis-
tent and chronic AF has been variable, but appears lower
(19,20).
Subsequently, Pappone et al. (21,22) developed a PV
isolation procedure based on encircling point-by-point ra-
diofrequency lesions placed in atrial tissue outside the
LA-PV junction and utilizing electroanatomical mapping.
The end point of the procedure was the recording of only
delayed low voltage (0.10 mV) far-field electrograms from
within the isolated area. Elimination of AF during
follow-up was reported in 85% of 179 patients with parox-
ysmal AF and 68% of 72 patients with chronic AF.
Successful outcome correlated poorly with the designated
procedural end points and was best predicted by a larger
percentage of total LA surface area incorporated within the
circular lesions.
It is with this perspective that the manuscript of Ernst et
al. (23), published in this issue of the Journal, is best
understood. These investigators examined the outcome of
linear radiofrequency ablation with a standard 4 mm elec-
trode guided by electroanatomical imaging in 84 patients
with predominantly paroxysmal AF. Four different strate-
gies for lesion deployment were evaluated, with systematic
use of electrophysiologic criteria to assess completeness of
conduction block across the ablation line. For the initial two
strategies, 1) a circular line around all four PVs with a
separate line connecting the circle to the posterior mitral
annulus, and 2) three separate nonencircling LA lines,
complete lines were rarely accomplished and consequently
elimination of AF during follow-up was uncommon. In
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addition to recurrence of AF, gaps in the nonencircling lines
promoted the occurrence of LA macroreentry (11% of
patients).
The final two strategies: 1) separate encircling lines
around the septal and lateral PVs, with an additional linear
connection between these circles and the posterior mitral
annulus, and 2) separate encirclement of the septal and
lateral PVs alone, without additional lines, mimic more
closely the method of Pappone et al. (21,22). These proce-
dures resulted in elimination of AF in nearly two-thirds of
patients during follow-up. Low voltage within the isolated
area was a poor predictor of outcome. However, elimination
of high frequency potentials within the isolated veins was
found to be relatively specific for a favorable outcome.
Inclusion of an additional long linear lesion between the PV
encircling lesions and the mitral annulus failed to improve
outcome and facilitated the occurrence of LA macroreentry.
Two patients had PV stenosis or occlusion, raising concerns
that the ostium may not have been appropriately visualized
before ablation.
How should the findings of Ernst et al. (5) influence our
conceptual approach to the ablation of AF? First, it is clear
that isolation of the PVs remains the cornerstone for
successful percutaneous ablation of AF. Second, this study
confirms the previously described technical difficulties and
potential proarrhythmia associated with long linear lesions
in the LA. Third, encircling linear lesions placed in atrial
tissue outside the PVs are a viable alternative to segmental
ostial isolation at the putative LA-PV junction.
Is the inclusion of LA tissue adjacent to the ostium
desirable during PV isolation? There are several reasons that
this may be so. The anatomy of the venoatrial junction is
complex, with both longitudinally and spirally oriented
fibers from the adjacent LA entering and investing the
media of the proximal PV (24–27). This region and the
adjacent proximal PVs are also the site of greatest electro-
gram fractionation, conduction slowing, and repolarization
heterogeneity, all potential substrates for reentry (28,29).
Left atrial tissue adjacent to the PV is the predominant
source of discrete high frequency periodic activity during
AF (30). Spontaneously discharging foci are frequently
found in atrial tissue near the LA-PV junction in both
experimental preparations (29) and in clinical experience
(19). It may be overly simplistic to envision the LA-PV
junction as a discrete anatomic ring. Rather, at least func-
tionally, it may be more useful to consider the junction as a
broader band incorporating both proximal venous and
adjacent LA tissue. Given the importance of this region, it
is perhaps surprising that there has been little rigorous
attention to the accurate assessment of the location of the
LA-PV junction during clinical procedures. Contrast
venography (16,17,19), intracardiac echo (31,32), and tissue
impedance (21,22) have each been used to identify the PV
ostium, but few attempts have been made to correlate these
techniques with each other, or with histologic and electro-
physiologic findings.
One attractive aspect of circular linear lesions placed
deliberately several millimeters outside the putative LA-PV
junction is that the impact of inaccuracies in locating this
structure and leaving behind a remnant of arrhythmogenic
tissue, may be minimized. In the experience of Pappone et
al. (21,22), high frequency potentials were identified at 35%
of LA sites thought to be adjacent to, but not within, the
PV. Both Pappone et al. (22) and Ernst et al. (23) found
that gaps in the peri-PV circular lesions, as demonstrated by
activation or voltage mapping, did not predict procedural
failure. The experience of Ernst and coworkers indicates
that the elimination of high frequency potentials within the
isolated area may be a better end point. Circular lesions
placed outside the os (when properly identified) may also
further reduce the risk of PV stenosis. Finally, targeting
atrial tissue outside the LA-PV junction may permit the safe
use of higher power applications that could reduce the
incidence of delayed recovery of activation within the PVs,
an important cause of recurrent AF after apparently suc-
cessful segmental ostial isolation procedures (17,19).
Strategies for the percutaneous ablation of AF continue
to evolve. It is likely that for some patients, such as those
with more extensive structural abnormalities, PV isolation
alone will be insufficient. However, until we are able to
reliably produce durable complete isolation of the PVs and
the LA-PV junction, it will be difficult to judge who may
benefit from additional long linear lesions, with their
attendant risk and extended procedural times, elsewhere in
the atria.
Reprint requests and correspondence: Dr. David J. Wilber,
Cardiovascular Institute, Loyola University Medical Center,
2160 South First Avenue, Maywood, Illinois 60153. E-mail:
dwilber@lumc.edu.
REFERENCES
1. Swartz JF, Perrersels G, Silvers J, et al. A catheter based curative
approach to atrial fibrillation in humans (abstr). Circulation 1994;90
Suppl:I35.
2. Cannom DS. Atrial fibrillation: nonpharmacologic approaches. Am J
Cardiol 2000;85:25D–35D.
3. Haissaguerre M, Jais P, Shah DC, et al. Right and left atrial
radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Car-
diovasc Electrophysiol 1996;12:1132–44.
4. Nademanee K, Kosar E, Mehra A, et al. Catheter-based MAZE
procedure for atrial fibrillation (abstr). Circulation 1998;98 Suppl:
I283.
5. Ernst S, Shluter M, Ouyang F, et al. Modification of the substrate for
maintenance of idiopathic human atrial fibrillation: efficacy of radio-
frequency ablation using nonfluoroscopic catheter guidance. Circula-
tion 1999;100:2085–92.
6. Pappone C, Oreto G, Lamberti F, et al. Catheter ablation of
paroxysmal atrial fibrillation using a 3D mapping system. Circulation
1999;100:1203–8.
7. Jais P, Shah DC, Haissaguerre M, et al. Efficacy and safety of septal
and left atrial linear ablation for atrial fibrillation. Am J Cardiol
1999;84:139R–46R.
8. Garg A, Finneran W, Mollerus M, et al. Right atrial compartmental-
ization using radiofrequency catheter ablation for management of
patients with refractory atrial fibrillation. J Cardiovasc Electrophysiol
1999;10:763–71.
1284 Wilber JACC Vol. 42, No. 7, 2003
Editorial Comment October 1, 2003:1283–5
9. Cox JL, Schuessler RB, Lappas DG, Boineau JP. An 8 1/2 year clinical
experience with surgery for atrial fibrillation. Ann Surg 1996;224:267–
75.
10. Kosakai Y, Kawaguchi AT, Isobe F, et al. Modified Maze procedure
for patients with atrial fibrillation undergoing simultaneous open heart
surgery. Circulation 1995;92 Suppl 9:II359–64.
11. Mitchell MA, McRury ID, Everett TH, Li H, Mangrum JM, Haines
DE. Morphological and physiological characteristics of discontinuous
linear atrial ablations during atrial pacing and atrial fibrillation.
J Cardiovasc Electrophysiol 1999;10:378–86.
12. Packer DL. Linear ablation for atrial fibrillation: the pendulum swings
back. In: Zipes DP, Haissaguerre M, eds. Catheter Ablation of
Arrhythmias. Armonk, NY: Futura, 2002:107–29.
13. Haissaguerre M, Jaı¨s P, Shah DC, et al. Spontaneous initiation of
atrial fibrillation by ectopic beats originating in the pulmonary veins.
N Engl J Med 1998;339:659–66.
14. Chen SA, Hsieh MH, Tai CT, et al. Initiation of atrial fibrillation by
ectopic beats originating from the pulmonary veins: electrophysiolog-
ical characteristics, pharmacological responses, and effects of radiofre-
quency ablation. Circulation 1999;100:1879–86.
15. Haissaguerre M, Jais P, Shah DC, et al. Electrophysiological end point
for catheter ablation of atrial fibrillation initiated from multiple
pulmonary venous foci. Circulation 2000;101:1409–17.
16. Haissaguerre M, Shah DC, Jais P, et al. Electrophysiological break-
throughs from the left atrium to the pulmonary veins. Circulation
2000;102:2463–5.
17. Macle L, Jais P, Weerasooriya R, et al. Irrigated-tip catheter ablation
of pulmonary veins for treatment of atrial fibrillation. J Cardiovasc
Electrophysiol 2002;13:1067–73.
18. Oral H, Knight BP, Tada H, et al. Pulmonary vein isolation for
paroxysmal and persistent atrial fibrillation. Circulation 2002;105:
1077–81.
19. Marrouche NF, Dresing T, Cole C, et al. Circular mapping and
ablation of the pulmonary vein for treatment of atrial fibrillation:
impact of different catheter technologies. J Am Coll Cardiol 2002;40:
464–74.
20. Haissaguerre M, Jais P, Shah DC, et al. Catheter ablation of chronic
atrial fibrillation targeting the reinitiating triggers. J Cardiovasc Elec-
trophysiol 2000;11:2–10.
21. Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency
ablation of pulmonary vein ostia: a new anatomic approach for curing
atrial fibrillation. Circulation 2000;102:2619–28.
22. Pappone C, Oreto G, Rosanio S, et al. Atrial electroanatomic
remodeling after circumferential radiofrequency pulmonary vein abla-
tion: efficacy of an anatomic approach in a large cohort of patients with
atrial fibrillation. Circulation 2001;104:2539–44.
23. Ernst S, Ouyang F, Lo¨ber F, Antz M, Kuck K–H. Catheter-induced
linear lesions in the left atrium in patients with atrial fibrillation: an
electroanatomic study. J Am Coll Cardiol 2003;42:1271–82.
24. Ho SY, Sanchez-Quintana D, Cabrera JA, Anderson RH. Anatomy
of the left atrium: implications for radiofrequency ablation of atrial
fibrillation. J Cardiovasc Electrophysiol 1999;10:1525–33.
25. Ho SY, Cabrera JA, Tran VH, Farre J, Anderson RH, Sanchez-
Quintana D. Architecture of the pulmonary veins: relevance to
radiofrequency ablation. Heart 2001;86:265–70.
26. Saito T, Waki K, Becker AE. Left atrial myocardial extension onto
pulmonary veins in humans: anatomic observations relevant for atrial
arrhythmias. J Cardiovasc Electrophysiol 2000;11:888–94.
27. Moubarak JB, Rozwadowski JV, Strzalka CT, et al. Pulmonary
veins–left atrial junction: anatomic and histological study. Pacing Clin
Electrophysiol 2000;23:1836–8.
28. Hocini M, Ho SY, Kawara T, et al. Electrical conduction in canine
pulmonary veins: electrophysiological and anatomic correlation. Cir-
culation 2002;105:2442–8.
29. Arora R, Verheule S, Scott L, et al. Arrhythmogenic substrate of the
pulmonary veins assessed by high-resolution optical mapping. Circu-
lation 2003;107:1816–21.
30. Mandapati R, Skanes A, Chen J, Berenfeld O, Jalife J. Stable
microreentrant sources as a mechanism of atrial fibrillation in the
isolated sheep heart. Circulation 2000;101:194–9.
31. Martin RE, Ellenbogen KA, Lau YR, et al. Phased-array intra-
cardiac echocardiography during pulmonary vein isolation and linear
ablation for atrial fibrillation. J Cardiovasc Electrophysiol 2002;13:
873–9.
32. Swarup V, Azegami K, Arruda MS, Burke MC, Lin AC, Wilber DJ.
Four vessel pulmonary vein isolation guided by intracardiac echocar-
diography without contrast venography in patients with drug refractory
paroxysmal atrial fibrillation (abstr). J Am Coll Cardiol 2002;39
Suppl:114A.
1285JACC Vol. 42, No. 7, 2003 Wilber
October 1, 2003:1283–5 Editorial Comment
